Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME Hyaluronic acid hydrolytic enzyme

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pain 3 D010146 ClinicalTrials
Multiple Myeloma 3 D009101 ClinicalTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 3 D020277 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Carcinoma, Renal Cell 3 D002292 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Primary Immunodeficiency Diseases 3 D000081207 ClinicalTrials
Smoldering Multiple Myeloma 3 D000075122 ClinicalTrials
Psoriasis 2 D011565 ClinicalTrials
Angioedemas, Hereditary 2 D054179 ClinicalTrials
Diabetes Mellitus, Type 1 2 D003922 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Dermatitis, Allergic Contact 2 D017449 ClinicalTrials
Diabetes Mellitus, Type 2 2 D003924 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Hypercholesterolemia 1 D006937 ClinicalTrials
Multiple Sclerosis 1 D009103 ClinicalTrials
Urinary Bladder Neoplasms 1 D001749 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Diabetes Mellitus 1 D003920 ClinicalTrials
Osteoporosis 1 D010024 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Related Entries

Mixture

Cross References

Resources Reference
CAS NUMBER 757971-58-7
ChEMBL CHEMBL1201718
FDA SRS 743QUY4VD8